Synthesis of polymer-lipid nanoparticles for image-guided delivery of dual modality therapy.
暂无分享,去创建一个
Robert Langer | Omid C Farokhzad | Zahi A Fayad | David P Cormode | Willem J M Mulder | YongTae Kim | Z. Fayad | R. Langer | O. Farokhzad | A. Mieszawska | I. van Rooy | D. Cormode | W. Mulder | A. Gianella | YongTae Kim | Bram Priem | Canturk Ozcan | Bram Priem | Anita Gianella | Aneta J Mieszawska | Inge van Rooy | Matthew P Labarre | Artiom Petrov | A. Petrov | C. Ozcan
[1] Chenjie Xu,et al. Size and Concentration Effect of Gold Nanoparticles on X-ray Attenuation As Measured on Computed Tomography. , 2008, Chemistry of materials : a publication of the American Chemical Society.
[2] H. Maeda,et al. Exploiting the enhanced permeability and retention effect for tumor targeting. , 2006, Drug discovery today.
[3] X. Sui,et al. Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery , 2012, International journal of nanomedicine.
[4] J. Dorsman,et al. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells. , 2007, Biochemical pharmacology.
[5] David J. Waxman,et al. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment , 2008, Molecular Cancer Therapeutics.
[6] Ming-hui Li,et al. HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia–reperfusion injury in rats , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.
[7] T. Park,et al. Biodegradable Nanoparticles Containing Doxorubicin-PLGA Conjugate for Sustained Release , 1999, Pharmaceutical Research.
[8] A. Secord,et al. Antiangiogenic Agents in Combination With Chemotherapy for the Treatment of Epithelial Ovarian Cancer , 2012, International Journal of Gynecologic Cancer.
[9] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[10] A. Karydas,et al. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[11] B. Sunderland,et al. An ion pairing approach to increase the loading of hydrophilic and lipophilic drugs into PEGylated PLGA nanoparticles. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[12] Axel Thran,et al. Atherosclerotic Plaque Composition : Analysis with Multicolor CT and Targeted Gold Nanoparticles 1 , 2010 .
[13] Robert Langer,et al. Mass production and size control of lipid-polymer hybrid nanoparticles through controlled microvortices. , 2012, Nano letters.
[14] F. Hirayama,et al. Cyclodextrin Drug Carrier Systems. , 1998, Chemical reviews.
[15] Volker Wagner,et al. The emerging nanomedicine landscape , 2006, Nature Biotechnology.
[16] Chad A Mirkin,et al. Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery. , 2011, Nano letters.
[17] Claudia Calcagno,et al. Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. , 2011, ACS nano.
[18] Robert Langer,et al. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile , 2012, Science Translational Medicine.
[19] Shiladitya Sengupta,et al. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system , 2005, Nature.
[20] Steven P Schwendeman,et al. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. , 2008, International journal of pharmaceutics.
[21] Nam-Trung Nguyen,et al. Micromixers?a review , 2005 .
[22] Roger A. Rajewski,et al. Cyclodextrins: Their Future in Drug Formulation and Delivery , 1997, Pharmaceutical Research.
[23] Z. Fayad,et al. Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging. , 2012, Chemical communications.
[24] K. Edwards,et al. Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids. , 2003, Biophysical journal.
[25] B. Rigas,et al. Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives. , 2012, Nanomedicine.
[26] J F Hainfeld,et al. Gold nanoparticles: a new X-ray contrast agent. , 2006, The British journal of radiology.
[27] Robert Langer,et al. Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. , 2008, ACS nano.
[28] R. Murray,et al. Does core size matter in the kinetics of ligand exchanges of monolayer-protected Au clusters? , 2005, Journal of the American Chemical Society.
[29] Mathias Brust,et al. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system , 1994 .
[30] Robert S. Kerbel,et al. The anti-angiogenic basis of metronomic chemotherapy , 2004, Nature Reviews Cancer.
[31] Mohammad Hedayati,et al. Preliminary study of injury from heating systemically delivered, nontargeted dextran-superparamagnetic iron oxide nanoparticles in mice. , 2012, Nanomedicine.
[32] K. Jensen,et al. Synthesis of micro and nanostructures in microfluidic systems. , 2010, Chemical Society reviews.
[33] D. Gewirtz,et al. Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. , 1994, Molecular pharmacology.
[34] J. Llovet,et al. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling , 2008, Molecular Cancer Therapeutics.
[35] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[36] J. Loo,et al. Cellular uptake of Poly‐(D,L‐lactide‐co‐glycolide) (PLGA) nanoparticles synthesized through solvent emulsion evaporation and nanoprecipitation method , 2011, Biotechnology journal.
[37] C. Mirkin,et al. Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation , 2012, Proceedings of the National Academy of Sciences.
[38] V. Fuster,et al. Effect of Computed Tomography Scanning Parameters on Gold Nanoparticle and Iodine Contrast , 2012, Investigative radiology.
[39] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.